Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Clinical trial NCT05887167 · RECRUITING
Trial details
- NCT number
- NCT05887167
- Sponsor
- Joshua Sasine, MD, PhD
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-02
- Primary completion
- 2026-12-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.